Greco, D.; Gualtierotti, R.; Agosti, P.; Adorni, M.P.; Ingegnoli, F.; Rota, M.; Bernini, F.; Meroni, P.L.; Ronda, N.
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study. J. Clin. Med. 2020, 9, 2157.
https://doi.org/10.3390/jcm9072157
AMA Style
Greco D, Gualtierotti R, Agosti P, Adorni MP, Ingegnoli F, Rota M, Bernini F, Meroni PL, Ronda N.
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study. Journal of Clinical Medicine. 2020; 9(7):2157.
https://doi.org/10.3390/jcm9072157
Chicago/Turabian Style
Greco, Daniela, Roberta Gualtierotti, Pasquale Agosti, Maria Pia Adorni, Francesca Ingegnoli, Matteo Rota, Franco Bernini, Pier Luigi Meroni, and Nicoletta Ronda.
2020. "Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study" Journal of Clinical Medicine 9, no. 7: 2157.
https://doi.org/10.3390/jcm9072157
APA Style
Greco, D., Gualtierotti, R., Agosti, P., Adorni, M. P., Ingegnoli, F., Rota, M., Bernini, F., Meroni, P. L., & Ronda, N.
(2020). Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study. Journal of Clinical Medicine, 9(7), 2157.
https://doi.org/10.3390/jcm9072157